Detalhe da pesquisa
1.
Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19.
Nat Immunol
; 23(1): 23-32, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34937933
2.
Xrn1-resistant RNA structures are well-conserved within the genus flavivirus.
RNA Biol
; 18(5): 709-717, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064973
3.
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
J Gen Virol
; 101(9): 925-940, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32568027
4.
Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants.
PLoS Pathog
; 13(5): e1006372, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28542609
5.
Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses.
PLoS Pathog
; 12(10): e1005982, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27783669
6.
Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression.
J Biol Chem
; 289(50): 34667-82, 2014 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25320088
7.
Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
J Gen Virol
; 96(Pt 4): 804-814, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25516543
8.
Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase.
Nat Commun
; 14(1): 1141, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854765
9.
An RNA pseudoknot is required for production of yellow fever virus subgenomic RNA by the host nuclease XRN1.
J Virol
; 84(21): 11395-406, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20739539
10.
A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses.
Vaccines (Basel)
; 9(12)2021 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34960238
11.
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease.
NPJ Vaccines
; 6(1): 39, 2021 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741993
12.
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.
J Exp Med
; 218(7)2021 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909009
13.
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.
Nat Commun
; 12(1): 324, 2021 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33436573
14.
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.
NPJ Vaccines
; 5: 91, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33083026
15.
Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs.
Vaccine
; 29(6): 1248-57, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21145373
16.
Conservation of the pentanucleotide motif at the top of the yellow fever virus 17D 3' stem-loop structure is not required for replication.
J Gen Virol
; 88(Pt 6): 1738-1747, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17485534
17.
Analysis of hepatitis C virus/classical swine fever virus chimeric 5'NTRs: sequences within the hepatitis C virus IRES are required for viral RNA replication.
J Gen Virol
; 84(Pt 7): 1761-1769, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12810870
18.
Evolution of naturally occurring 5' non-translated region variants of hepatitis C virus genotype 1b in selectable replicons.
J Gen Virol
; 85(Pt 7): 1859-1866, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15218170